MYDA Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

MYDA Advisors’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,000	Closed	-$535K	–	350
2021 Q1	$535K	Sell	5,000 -1,000	-17%	-$104K	0.15%	166
2020 Q4	$524K	Buy	+6,000	New	+$424K	0.16%	119
2020 Q3	–	Sell	-18,000	Closed	-$872K	–	159
2020 Q2	$872K	Buy	+18,000	New	+$860K	0.53%	51

Other funds holding NARI

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

DCP

Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MYDA Advisors's NARI Position: Q2 2021 in Review

MYDA Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2021, closing a stake of 5,000 shares — an estimated $535K sold.

MYDA Advisors first reported a position in NARI in Q2 2020 and held it in 3 quarters. The position peaked at $872K in Q2 2020. 202 funds tracked by Wall St. Rank hold NARI as of Q2 2021.

MYDA Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
MYDA Advisors sold 5,000 Inari Medical, Inc. Common Stock shares in Q2 2021, an estimated $535K.
MYDA Advisors first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
MYDA Advisors's Inari Medical, Inc. Common Stock position peaked at $872K in Q2 2020.
202 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2021.

Based on MYDA Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.